Adaptation to carbohydrate and fat intake involves changes in a number of biochemical parameters at the cellular level. A change in the concentration of fat or carbohydrate in the blood acts directly to in¯uence metabolic pathways by altering the¯ux of intermediates into cells. This in turn alters the concentration of hormones and other signaling molecules and changes the rate of expression of genes coding for key regulatory proteins or enzymes in metabolic pathways. These effects occur at different rates and in a tissue-speci®c manner in response to diet. A key metabolic adaptation involves changes in the level of expression of genes coding for proteins of critical importance in energy metabolism; this is largely due to an altered rate of transcription of selected genes under the control of hormones and/or carbohydrate and lipid. The mediators of this effect are transcription factors, that is, nuclear proteins which integrate the effects of hormones and substrates with the transcription process by binding to response elements in the promoters of regulated genes and interacting with the transcription machinery at the TATA box, thereby altering the activity of RNA polymerase II. In this review we will outline the hierarchy of cellular adaptations to diet and will emphasize the latest concepts of gene regulation in response to metabolites and hormones. In particular, we will review the role of the various transcription factors involved in the regulated expression of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.132), a key gluconeogenic enzyme.
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Overview of the hierarchy of metabolic responses at the cellular level to dietary carbohydrate and lipid
Food ingestion initiates a complex series of adaptive responses at the cellular level. The quality and abundance of fuels from the diet patterns the response at the cellular level since metabolic adaptation begins with the increased availability of a speci®c substrate, such as glucose or fatty acids, which in turn triggers an entire panoply of additional adaptations. In discussing these responses it is convenient to classify them on a temporal basis from the most immediate to the longer-term metabolic effects. Table 1 lists these responses in the approximate order in which they occur and provides examples of regulated steps in metabolic pathways which are responsive to alterations in dietary carbohydrate and fatty acids. In this article we will concentrate on the alterations in gene expression induced in response to the ingestion of carbohydrate and fat and to starvation and will brie¯y review examples of the hierarchy of cellular responses. Considering the scope of the biochemical adaptations involved it will only be possible to cite selected examples of regulation in each of these categories of metabolic control.
Immediate cellular effects of fuel intake
Substrate-speci®c effects. An increased availability of metabolic fuels such as glucose and fatty acids elevates the uptake and¯ux of intermediates along metabolic pathways in cells of speci®c tissues. When the concentration of glucose in the blood increases from 5 mM to a post-prandial 10 mM, for example, there is a rapid increase in the rate of glucose entry into the liver. This redirects speci®c enzymatic steps involved in glucose metabolism within the hepatocytes toward glycogen synthesis and away from glycogen breakdown and glucose synthesis. Many of these biochemical effects are substrate speci®c and do not require the immediate action of increased (or decreased) hormone secretion to be manifest. The availability of intermediates in a metabolic pathway can, by mass action, increase¯ux over the pathway thereby creating a new metabolic steady-state in a speci®c tissue such as the liver or muscle. The important role of the family of glucose transporters in controlling the uptake of glucose from the blood should also be emphasized as a critical element in regulating the clearance of blood glucose (Sliverman, 1991) .
Hormone-speci®c effects. A meal containing suf®cient carbohydrate to cause an elevation in the concentration of blood glucose will stimulate the secretion of insulin from the b-cells of the pancreas. This increases the rate of uptake of glucose and amino acids by muscle and adipose tissue by causing a dramatic translocation of the glucose transporter, GLUT 4 to the cell membrane in these tissues. Hormonal effects are generally rapid in onset (seconds to minutes) after the initial stimulus and can set in motion a number of downstream events ranging from a stimulation of transport to an alteration in gene expression. Therefore, while the initial secretion of a hormone may be considered as an immediate response to dietary alterations, the overall in¯u-ence that a hormone has on speci®c metabolic process may be far more removed in time.
Intermediate cellular effects
Allosteric modi®cation of key regulatory steps in a metabolic pathway. A more delayed effect which occurs at the cellular level within minutes after the intake of a meal high in carbohydrate involves the allosteric modi®cation of speci®c enzyme steps in response to an alteration in the availability of a speci®c metabolite. As the concentration of intermediates in a metabolic pathway is altered to reach a new steady-state re¯ecting the macronutrient composition of the meal, the levels of a number of critical regulatory molecules are altered, which allosterically modify enzymes at key points in a metabolic pathway (for a review see Pilkis & Claus, 1991) . This is a major paradigm in metabolic regulation and involves both intermediates and end products of metabolic pathways. For example, glycogen, the end-product of the pathway of glycogen formation, inhibits the activity of glycogen synthase, while alanine, a major precursor of glucose production in the liver, inhibits L-type pyruvate kinase thus preventing excess futile cycling of carbon destined for glucose (Blair et al, 1976) . A rise in the concentration of citrate, an intermediate in the citric acid cycle, allosterically activates acetyl CoA carboxylase (Brownsey & Denton, 1987) , the rate controlling enzyme in the pathway of de novo fatty acid synthesis in the liver. This complex pattern of regulation often involves intermediates in one metabolic pathway interacting to control the¯ux of intermediates over another, related pathway in order to co-ordinate the synthesis or degradation of critical metabolic fuels (Pilkis & Granner, 1992) .
Covalent modi®cation of regulatory proteins. The effects of hormones on metabolic pathways often involves covalent modi®cation of enzymes (or other critical proteins such as transcription factors) by phosphorylation, catalyzed by a protein kinase and then by subsequent dephosphorylation via a phosphoprotein phosphatase. There are a variety of protein kinases, ranging from the dedicated protein kinase associated with the E1 subunit of the pyruvate dehydrogenase complex (Reed et al, 1985) to the cAMP-dependent protein kinase (PKA) which phosphorylates speci®c proteins in response to alterations in the concentration of cAMP induced by hormones such as glucagon and norepinephrine. Conversely, the rate of dephosphorylation of a rate controlling protein in a metabolic pathway by a phosphoprotein phosphatase (Phosphoprotein phosphatase 1) can be a major factor in altering metabolic¯ux along that pathway (Cohen & Cohen, 1989 ). An example of the interaction of protein kinase A and phosphoprotein phosphatase 1 is readily illustrated by the control of glycogen metabolism in the liver. During fasting there is a gradual increase in the concentration of glucagon in the blood which results in a subsequent rise in the levels of cAMP in the liver. This in turn activates protein kinase A which has as one of its critical target proteins glycogen phosphorylase kinase, a multi-subunit kinase which, when activated by PKA-mediated phosphorylation, can phosphorylate and activate glycogen phosphorylase (Johnson, 1992) . This leads to the phosphorolytic cleavage of a glucosyl residue from hepatic glycogen to yield glucose-1-phosphate, which will subsequently be converted to glucose-6-phosphate and then to glucose, which is released from the liver. The activity of phosphoprotein phosphatase 1 is maintained at a low level during starvation due to the PKA-mediated phosphorylation of an inhibitory protein which binds to the phosphatase. There is thus control of glycogen degradation by cAMP during fasting which can both activate glycogen phosphorylase by phosphorylation and inactivate phosphoprotein phosphatase 1, therefore preventing the futile cycling of glucosyl units from glycogen. The ingestion of carbohydrate reverses the effects described above by lowering the output of glucagon from the a-cells of the pancreas, thus lowering the levels of hepatic cAMP. The concomminant increase in the rate of secretion of insulin from the b-cells of the pancreas also activates a series of counterregulatory steps, beginning with a regulatory cascade involving MAP kinase, the activation of which results in the activation of glycogen synthase. It has also been proposed that the phosphorylation of glucose in the liver by glucokinase increases the concentration of glucose-6-phosphate which then binds to the inactive glycogen synthase D, promoting the dephosphorylation and activation of glycogen synthase (Villar-Palasi & Guinovart, 1997) . Such a mechanism is of interest since it links the uptake of glucose by the liver with the enzymatic dephosphorylation of the inactive form of glycogen synthase. Since GLUT 2, the main glucose transporter in the liver has a relatively high K m for glucose (13.2 mM) and, in the human, the ambient concentration of glucose in the blood of a healthy individual is normally about 5 mM, the uptake of glucose by the liver is directly related to the concentration of glucose in Table 1 Time course of the effect of fuels on metabolic processes with selected examples of regulated steps
Short term (seconds)
Hormone secretion. Insulin secretion rises in response to an elevation in the concentration of blood glucose Fuel uptake by target tissue. Glucose uptake by the liver Mass action effects of intermediates of fuel metabolism on speci®c enzyme steps. An increase in hepatic glucose-6-phosphate inhibits the activity of hexokinase 2. Intermediate term (minutes)
Allosteric regulation of speci®c enzymes in a metabolic pathway. An increase in the concentration of glucose-6-phosphate inhibits the activity of glycogen phosphorylase Covalent modi®cation of enzymes and regulatory molecules. An increase in the concentration of cAMP in the liver inhibits the activity of pyruvate kinase 3. Long term (minutes to hours)
Alterations in the rate of synthesis of enzymes at key regulatory steps in metabolic pathways. An increase in the concentration of cAMP in the liver elevates the concentration of hepatic mRNA for PEPCK and induces the rate of PEPCK synthesis Alterations in the level of gene expression. Glucose induces transcription of the gene for pyruvate kinase in the liver
Molecules and cellular adaptations to carbohydrate and fat intake P Leahy et al the blood. It is clear, therefore, that the dietary intake of carbohydrate and the subsequent elevation of blood glucose, plays a critical role in controlling its deposition as glycogen in the liver. An example of the interplay between diet and hormones and the profound effects they have on hepatic metabolism is the response to starvation of two metabolic pathways, glycolysis and gluconeogenesis (Pilkis et al, 1995) . The adaptation in these two pathways also illustrates the role played by both allosteric modi®cation of key enzymes in both pathways and the control exerted by covalent modi®cation of critical enzymes in response to a rise in cAMP. During fasting, hepatic gluconeogenesis becomes increasingly important for the maintenance of glucose homeostasis (Ruderman et al, 1976) . The increase in the concentration of hepatic cAMP (discussed above) due to a rise in serum glucagon is a major factor in regulating the response of the liver to starvation. In the case of gluconeogenesis, this control is exerted by inactivation of the L-type pyruvate kinase via phosphorylation of the enzyme and by the regulation of the concentration of the important regulatory molecule, fructose-2,6-bisphosphate. Phosphofructokinase (PFK-1), the rate controlling step in glycolysis, is stimulated by fructose-2,6-bisphosphate, which binds to an allosteric activation site on the enzyme and reverses the inhibition of PFK-1 activity exerted by ATP and or citrate (Pilkis et al, 1995) . The concentration of fructose-2,6-bisphosphate in hepatocytes is determined by the activity of a bi-functional enzyme, fructose-2,6-phosphatase/fructose-6-phosphate kinase (PFK-2). This enzyme is very unusual in biology since it can function as both a kinase or as a phosphatase depending upon its state of phosphorylation by a protein kinase A (among other regulatory factors which in¯uence the direction of its activity). When PFK-2 is phosphorylated, it acts as a phosphatase and removes the phosphate from fructose-2,6-bisphosphate, therefore lowering the concentration of that very important allosteric activator of PFK-1. In addition, fructose-2,6-bisphosphate is a negative regulator of the gluconeogenic enzyme fructose-1,6-bisphosphatase (Pilkis et al, 1995) . A decrease in the concentration of fructose-2,6-bisphosphate therefore decreases the rate of glycolysis and increases the rate of gluconeogenesis by acting to control the relative activities of PFK-1 and FBPase in a reciprocal fashion. Since cAMP is the major factor which determines the level of fructose-2,6-bisphosphate in the liver, it serves to integrate the effects of hormones (glucagon and insulin) on hepatic metabolism. The major adaptation caused by alterations in dietary carbohydrate are therefore focused on controlling critical, rate-limiting steps in opposing metabolic pathways (gluconeogenesis and glycolysis) ensuring an appropriate balance between the two pathways, depending upon the metabolic situation.
Long-term cellular effects: alterations in gene expression
Alterations in the carbohydrate and fat content of the diet have a profound effect on gene expression, causing an increase (or decrease) in the concentration of speci®c proteins critical for the function of a metabolic pathway. This process involves gene transcription, RNA transport from the nucleus and subsequent processing, protein synthesis and in some instances, the post-transitional modi®ca-tion of the protein. Alterations in the diet may also be involved in the control of protein degradation. The time course for these effects generally takes hours to be fully manifested in an altered pro®le of enzymes and other proteins required for an adaptive metabolic response. However, this process may be very rapid; expression of the gene c-fos occurs within minutes after a stimulus, such as partial hepatectomy (Mohn et al, 1990) . While control of gene expression by diet is a coordinate process and regulation can occur at each of the steps mentioned above, the transcription of speci®c genes can be responsive to adaptations in dietary intake (Hsiu-Ming & Towle, 1992; Thompson & Towle, 1991; Lamers et al, 1982; Patel et al, 1994) . The initiation of gene transcription involves the activation of transcription factor(s) which is the culmination of a signal transduction pathway initiated by changes in dietary intake and composition. The signaling events which are involved in altering gene transcription also effect a variety of related regulatory steps, thereby co-ordinating metabolic ux within a cell. Due to the sheer scope of this ®eld and Molecules and cellular adaptations to carbohydrate and fat intake P Leahy et al S8 the limited space for this review, we will use as an example the dietary control of the expression of the gene coding for the cytosolic form of the key gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK).
Dietary control of PEPCK gene expression
Background on the control of PEPCK gene expression by diet The gene for PEPCK is expressed in the liver, kidney cortex, adipose tissue, the jejunum and the mammary gland during lactation. A detailed discussion of the physiological role of the enzyme in these various tissues can be found in a recent review (Hanson & Patel, 1994) . In the liver and kidney cortex, PEPCK is involved in gluconeogenesis and increases in activity under conditions when the level of blood glucose is low (liver) or during metabolic acidosis (kidney). The major site of regulation is at the level of gene transcription (Granner et al, 1983; Lamers, 1982) , although there is evidence that PEPCK mRNA is stabilized from degradation by cAMP (Hod & Hanson, 0000) . Dietary carbohydrate is a major factor in controlling the rate of PEPCK gene expression. The ingestion of a carbohydrate-rich meal causes insulin secretion, which in turn rapidly depresses hepatic PEPCK gene transcription (Granner et al, 1983) . Conversely, starvation or a diet devoid of carbohydrate, which causes a drop in insulin and a rise in glucagon (which acts via cAMP), induces PEPCK gene transcription (Lamers et al, 1982; Short et al, 1986; Quinn et al, 1988) . The effect of insulin and glucagon on PEPCK gene transcription is very rapid. In 30 min the rate of transcription of the gene for PEPCK decreases by 50%, whereas the injection of cAMP to an animal results in a 10-fold induction in PEPCK gene transcription within 15 min after its administration to carbohydrate fed rats (Lamers et al, 1982) .
The control of PEPCK gene transcription by diet is exerted through a relatively small region (1000 bp) of the PEPCK gene promoter immediately 5
H to the start-site of transcription (McGrane et al, 1988 (McGrane et al, , 1990 Patel et al, 1994; Short et al, 1992; Eisenberger et al, 1992) , which contains a number of regulatory elements that bind speci®c transcription factors (Figure 1 ). These transcription factors are recruited to bind to the promoter by stimuli such as a rise and fall in the intracellular concentration of cAMP or by a change in the levels of insulin or glucocorticoids in the blood in response to alterations in dietary carbohydrate. After binding to the PEPCK gene promoter, these transcription factors interact with one another and with a series of proteins that link the transcription factors to proteins binding at the TATA box region of the promoter (the transcription complex). This complex then activates RNA polymerase II that transcribes the PEPCK gene (Figure 2) .
Organization of the PEPCK gene promoter
The PEPCK gene promoter contains several regions with clusters of regulatory elements that bind transcription factors ( Table 2 ). The organization of the regulatory elements within these regions of the promoter allows the direct contact of the transcription factors, facilitating their interactions (Figure 1 ). For example, within Region I there is a cAMP regulatory element (CRE) which is adjacent to a Nuclear Factor 1 (NF-1) binding site (Roesler et al, 1989) . The proteins that bind to these sites interact to control the extent of PEPCK gene transcription in the basal and cAMPstimulated state. NF-1 has a strong negative effect on PEPCK gene transcription (Leahy & Hanson, unpublished results). Region 2 of the PEPCK gene promoter contains a liver-speci®c (P3(I) and a kidney-speci®c (P2) regulatory element as well as a thyroid hormone regulatory element (TRE) (Giralt et al, 1991) . Region 3 consists of a glucocorticoid regulatory unit (GRU) with a glucocorticoid regulatory element, an insulin regulatory element (IRE) and several accessory protein binding sites that are required for the appropriate response of the transcriptional unit to insulin (O'Brien et al, 1990; Imai et al, 1990) . Finally, Region 4 of the PEPCK gene promoter is speci®c for the expression of the PEPCK gene in adipose tissue due to the presence in that region of a PPARg binding site (Tontonoz et al, 1995) . The functional interaction of these regulatory elements within the promoter is critical for the appropriate development and tissue-speci®c expression of the gene for PEPCK and for its transcriptional response to diet.
Transcriptional control is exerted by the interaction of speci®c transcription factors, which bind to regulatory elements in the promoter and with the a complex of proteins which bind at the TATA box (733 to 729 in the PEPCK gene). Interaction between these proteins Figure 1 for more details.
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results in the activation of RNA polymerase II and the subsequent transcription of the gene. A critical element in this transcriptional response complex is CBP/p300, a large, multidomain protein which binds to activator proteins such as CREB and C/EBP, the thyroid hormone receptor, the glucocorticoid receptor and Fos/Jun, which themselves are bound to the promoter of speci®c genes (Shikama et al, 1997) . CBP/p300 can be phosphorylated by the catalytic subunit of protein kinase A, making it a critical factor in the cAMP induction of transcription of the PEPCK gene and of other genes induced by starvation (Montminy, 1997) . The complexity of the interaction of proteins on the gene promoter is only now being fully characterized. Individual transcription factors can cause a stimulation of transcription of a gene but a combination of the factors is required for maximum transcription; this effect on transcription is often synergistic and co-operative in nature (Kim & Maniatis, 1998) . The transcription factors form a`protein surface' on the promoter which is critical for the stereospeci®c linkage between the regulatory elements in the promoter and the transcriptional machinery at the TATA box. In addition, CBP/P300 interacts with associated factors, based on the assembly properties of the complex (Korzus et al, 1998) . Figure 2 illustrates the complex of transcription factors which bind to the PEPCK promoter.
De®ning the effect of diet and hormones on regulatory elements in the PEPCK gene promoter using transgenic mice A full understanding of the effect of diet and hormones on PEPCK gene transcription requires analysis using the intact animal. Our understanding of the function of speci®c regulatory elements of the PEPCK gene has greatly bene®ted from the use of mice with transgenes containing the PEPCK promoter with mutations in putative regulatory elements. Using these mice, Patel et al, 1994 established that the CRE and P3(I) elements are necessary for the response of the PEPCK gene promoter to starvation and that the P3(I) regulatory element is involved in the liver speci®c expression of the PEPCK gene in these mice. In addition. the P2 regulatory element was shown to be required for the expression of the PEPCK gene in the kidney. A deletion of the GRU results in a failure of the PEPCK gene promoter in these transgenic mice to respond to diabetes and to glucocorticoids (Friedman et al, 1993) . Interestingly, we were unable to identify an element in the PEPCK gene promoter which is involved in the very strong inhibitory effect of a high carbohydrate diet on transcription from the PEPCK gene promoter , suggesting that there may be additional sites on the promoter which are involved in the effect of glucose on the expression of this gene. Using transgenic mice, Short et al, 1992 identi®ed a region of the PEPCK gene promoter between 7600 and 71000 which was involved in the adipose tissue speci®c expression of the PEPCK gene; a PPARg site was later identi®ed at 7980 in the promoter (Tontonoz et al, 1995) . Therefore, despite the expense of introducing the transgene and the subsequent maintenance of the animals, transgenic mice have been invaluable for studying the dietary and hormonal regulation of gene expression.
Families of transcription factors are involved in the dietary control of PEPCK gene transcription
Most of the regulatory elements in genes studied to date have the capacity to bind to individual members of multiprotein families of transcription factors. This greatly complicates an understanding of which of the speci®c transcription factors is involved in the control of PEPCK expression during adaptation to diet. As an example of this problem, Table 2 presents a list of the transcription factors known to be involved in PEPCK gene transcription and indicates the hormonal or dietary stimuli which operate via that speci®c transcription factor (a similarly complex table could be constructed for other genes which code for proteins which are important in metabolic processes). There are multiple transcription factors which bind to the various regulatory element of the PEPCK gene promoter and several of these proteins bind to multiple elements (Hanson & Reshef, 1997) . The factors involved in the cAMP induction of PEPCK gene transcription provide an interesting paradigm of the problems involved in sorting out the speci®c interaction of transcription factors necessary for a response of the gene to diet and hormones. The major regulation of PEPCK gene transcription by starvation or by a high protein/carbohydrate-free diet, both of which cause a rise in hepatic cAMP, is exerted through the CRE located in Region 1 of the PEPCK gene promoter in coordination with the P3(I) regulatory element . The CRE in the PEPCK gene promoter binds the cAMP regulatory element binding protein (CREB) (Quinn, 1993; Roesler et al, 1995) , AP-1 (fos-jun heterodimers) (Gurney et al, 1992) and members of the C/EBP family of transcription factors (of which there are currently 5 members) (Park et al, 1990; Croniger et al, 1997; Roesler et al, 1992) . Therefore multiple transcription factors can bind to the same regulatory element of the PEPCK gene promoter and can also stimulate transcription from that promoter as determined using in vitro transcription assays (Roesler et al, 1992; Park et al, 1990) . Molecules and cellular adaptations to carbohydrate and fat intake P Leahy et al
This redundancy in the function of transcription factors in the control of gene transcription at the same regulatory element in a promoter suggests that different factors are used in different tissues to determine the tissue-speci®c expression of the gene or that a transcription factor is recruited to a regulatory element on a promoter under the in¯uence of speci®c stimuli, such as diet or hormones. An example of this type of regulation is the control of PEPCK gene transcription by cAMP. As noted above, both the CRE and the P3(I) sites on the PEPCK promoter are required for the full stimulatory effect of cAMP on PEPCK gene transcription . Multiple transcription factors bind to the CRE and activate transcription from the PEPCK promoter (see Table 1 ); these include CREB (Roesler et al, 1989) , CREMa and CREMt (Goraya et al, 1995) AP-1 (Fos/Jun heterodimers or Jun/Jun homodimers) (Gurney et al, 1992) , and members of the C/EBP family of transcription factors (C/EBPa (Roesler et al, 1989) , C/ EBPb (Park et al, 1990 ) and D-binding protein (Roesler et al, 1992) ). The P3(I) site is known to bind only members of the C/EBP family of transcription factors (Roesler et al, 1989) . A major problem in this ®eld has been determining which of this array of transcription factors is active in the animal and how diet and hormones in¯uence their ability to activate PEPCK gene transcription under various physiological conditions.
Gene`knock-out' mice as a tool for determining the dietary control of gene transcription A valuable tool in de®ning the role of speci®c transcription factors in the control of metabolic processes are mice containing deletions in the genes for individual transcription factors. It is possible, for example, to conclude that CREB, which is known to activate transcription from the PEPCK promoter in cells in culture, is not required for the normal regulation of hepatic PEPCK gene transcription since deleting the gene for CREB did not cause alterations in glucose homeostasis in the mice (Hummler et al, 1994) . However, a deletion of the gene for C/EBPa resulted in mice which died of profound hypoglycemia in the period immediately after birth (Wang et al, 1995) . In addition, the absence of the gene for C/EBPa results in mice which were unable to respond to the normal induction of hepatic PEPCK gene transcription by cAMP. From this type of analysis it is possible to conclude that C/EBPa is a major transcription factor involved in the control of PEPCK gene expression by starvation (a rise in hepatic cAMP).
An added complexity has been noted in studies with mice in which there is deletion in the gene for C/EBPb. Mice homozygous for a deletion in the gene for C/EBPb were initially generated to study the effects of C/EBPb on the interleukin-6 (IL-6) signaling pathway. Screpanti and colleagues (Screpanti et al, 1995) reported that the mice developed a pathology similar to animals which overexpress IL-6; they have splenomegaly, peripheral lymphadenopathy, enhanced hemopoiesis and an altered T-helper function. Despite these problems with the immune system, the mice had no overt disruption of glucose homeostasis (Screpanti et al, 1995) . However, both Screpanti et al, 1995 and Tanaka et al, 1995 noted a failure to obtain the expected Mendelian ratio of mice heterozygous for a deletion in the gene for C/EBPb, although the appropriate number of C/EBPb 7 /-mice were present at 18 d of fetal life. Croniger et al, 1997 reported that there are two phenotypes noted with the C/EBPb 7 /-mice. Animals with phenotype A live until about 4±6 months of age and die of problems associate with a severely compromised immune system, while the other half of the C/EBPb 7 /-mice, those with phenotype B die within the ®rst hour after birth of profound hypoglycemia. The livers of the animals with phenotype B contain normal levels of glycogen, which is not mobilized appropriately by the administration of Bt 2 cAMP to the newborn animals. The mice with phenotype B also have no detectable PEPCK mRNA in their livers and are thus unable to synthesize glucose. The injection of Bt 2 cAMP into these mice 2 h after delivery induced the appearance of PEPCK mRNA, indicating that the gene is responsive to the cyclic nucleotide even in the absence of C/EBPb. As mentioned above, the PEPCK gene in the livers of C/EBPa 7 /-mice will not respond to the cyclic nucleotide when injected 2 h after delivery. These ®ndings clearly demonstrate that C/EBPa, and not C/EBPb, is required for the response of PEPCK gene transcription to cAMP during the perinatal period.
The reason why there are two different phenotypes noted with the C/EBPb 7 /-mice is not clear. We assume that there are factors produced in the mice with phenotype A which allows them to transcribe genes critical for survival during the perinatal period. These`modi®er genes' are expressed as a result of the genetic background of the mice, which are not inbred. This possibility is supported by preliminary experiments in which mice homozygous for a deletion of the gene for C/EBPb were back-crossed with C57BL6 mice; no C/EBPb 7 /-offspring from these matings survived after birth (Poli, unpublished observations). One simple explanation for this result is that the gene(s) for other member(s) of the C/EBP family of transcription factors are up-regulated in mice with the A phenotype, permitting their survival through the perinatal period. However, there is no apparent up-regulation in the expression of the gene for C/EBPa or C/EBPd (Poli, unpublished observations) in the livers of the C/EBPb 7 /-mice; the level of expression of the genes for the other members of the C/EBP family has not as yet been investigated in detail.
These studies demonstrate the complex nature of the interactions between transcription factors in the control of expression of the gene for PEPCK. It is probable that additional transcription factors involved in the regulation of PEPCK gene transcription will be identi®ed, despite the large number currently known to be involve in controlling the transcription of this key gene. While we now have a good beginning in our understanding of the speci®c proteins which regulate PEPCK gene transcription there are important areas of control which need clari®cation. For example, the availability of reagent-grade proteins which activate transcription in a reconstituted, cell-free system would allow a more critical assessment of the function of individual proteins in the control of PEPCK gene transcription and the regulatory role of speci®c signaling molecules known to be responsive to diet.
Summary and prospective for future research in this area
In the past our understanding of the mechanism of dietary adaptations in humans was limited to the measurement of metabolites and hormones in the blood and the determination of the¯ux of fuels along metabolic pathways in various tissues. The isolation and characterization of the Molecules and cellular adaptations to carbohydrate and fat intake P Leahy et al genes which code for proteins involved in the response to diet has opened a new and exciting chapter in metabolic research. Changes in the rate of gene transcription are now known to be a central event in the response of an individual to dietary changes. Transcription factors, which interact with regulatory molecules recruited in response to dietary (hormonal) changes are critical players in our adaptation to dietary changes. The complete human gene sequence will provide a resource for identifying new genes (and hence proteins) which play a regulatory role in metabolic adaptations. In addition, animal models for disease will play an increasingly important role in metabolic studies since it will be possible to develop mice with mutations in critical, but as yet unknown genes which are required for metabolic responses. Since diseases such as diabetes and obesity are multifocal disorders, the use of functional genomics to generate animals with multiple gene defects which mimic metabolic diseases will provide a hitherto unavailable tool for studying metabolic responses to diet. Transcription factors, while pleiotropic in function, are none-the-less major players in the cellular response to changes in diet, since they are often the critical target of signalling pathways initiated by dietary changes. Much remains to be learned about the details of their functioning in the nutritional control of gene expression.
